Harmony Biosciences Holdings, Inc. (HRMY) Covered Calls

You can sell covered calls on Harmony Biosciences Holdings, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for HRMY (prices last updated Fri 4:16 PM ET):

Harmony Biosciences Holdings, Inc. (HRMY) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
33.22 +0.22 30.85 33.22 588K 16 1.9
Covered Calls For Harmony Biosciences Holdings, Inc. (HRMY)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 20 35 1.00 32.22 3.1% 31.4%
Jan 17 35 1.50 31.72 4.7% 26.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients living with rare neurological disorders. Its lead product includes WAKIX (pitolisant) for the treatment of pediatric patients suffering from narcolepsy. Harmony Biosciences Holdings, Inc. was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. The company was founded in 2017 and is based in Plymouth Meeting, Pennsylvania.